Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Life Technologies Sets New Worldwide Standard for Criminal Forensic Testing with Introduction of GlobalFiler™ Kit

Published: Sunday, October 14, 2012
Last Updated: Sunday, October 14, 2012
Bookmark and Share
New kits compare broadest range of genetic data to help labs reduce evidence backlogs faster and solve crimes more cost effectively

Life Technologies Corporation (NASDAQ: LIFE), a leader in human identification solutions, has launched GlobalFiler™  and GlobalFiler™ Express, two new DNA kits that will revolutionize how crime labs perform forensic testing around the world -- making it faster, easier and cheaper to process DNA samples.

By increasing the number of genetic markers by over 30% to 24, GlobalFiler™ delivers the ability to recover significantly more information from forensic samples and increases discrimination power by up to 9 orders of magnitude.  This results in faster and more powerful comparisons of forensic data to resolve crimes.  Combined with five times faster processing efficiency, this powerful advancement will enable forensic scientists to solve and prevent more crime while addressing ever-growing backlogs.  To date, 44 countries have now implemented criminal offender DNA database programs with a combined offender sample pool of 40 million and growing.

"I've been very impressed with GlobalFiler's performance," said Professor Walther Parson, Ph.D., a leading world expert in forensic DNA testing in Innsbruck, Austria.  "It's extremely high discrimination power will greatly facilitate intelligence databasing and solving of national and cross-border crime."

GlobalFiler™ and GlobalFiler™ Express kits feature a new, proprietary chemistry that enables 48 samples to be processed in under two hours when combined with Life Technologies' forensic testing systems -- five times faster than other solutions currently on the market.  It also facilitates quicker and improved amplification of challenging samples, such as degraded human remains. All combined, the new kits offer forensic science customers an unsurpassed standard in rapid DNA processing from sample-to-result.

For more than 25 years, Life Technologies has led the development and commercialization of the industry's most trusted and reliable forensic solutions for human identification (HID) testing.  It is also the only company in the world that designs and validates its reagents, instruments and data analysis software together as an integrated system for HID testing.

"No other company understands the needs of forensic scientists better than we do and as a result, we have delivered a product that will dramatically change the way forensic testing is done on a global scale," said John Gerace, Head of Applied Sciences for Life Technologies.  "We know that time and costs are of critical importance when it comes to solving crimes."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Acquisition Approved by Life Technologies Stockholders
Company announced that its stockholders voted to adopt the previously announced merger agreement.
Thursday, August 22, 2013
Life Technologies Announces First Quarter 2013 Results
Revenue increased 2.5% to $963 million.
Friday, May 03, 2013
Life Technologies Acquires Compendia Bioscience
Acquisition of a preeminent cancer bioinformatics company enhance's Life's diagnostic development capabilities across multiple platforms
Sunday, November 11, 2012
Life Technologies introduces Ion AmpliSeq™ Community Panels
Ion AmpliSeq™ Community Panels leverages the expertise of scientific thought leaders and the Ion Community to create gene panels for conditions ranging from cancer to inherited diseases.
Wednesday, November 07, 2012
Life Technologies Acquires Compendia Bioscience
Acquisition expands Life Technologies' ability to drive progress in personalized medicine
Sunday, October 14, 2012
Life Technologies Names Alan Sachs as Head of Global Research and Development
Sachs brings more than 20 years of experience as a research scientist and a leader in developing innovative scientific platforms.
Wednesday, February 01, 2012
Scientific News
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Human Evolution Driven by Viruses
Study finds surprising percentage of protein adaptions in humans have been driven by viruses.
Earliest Sign of Alzheimer's Development Discovered
Researchers have identified the first physiological signs of late-onset Alzheimer's disease, underlining the importance of computational power in neurology.
Computational Method Offers Significant Boost in Finding New Cancer Targets
MIT and ARIAD Pharmaceuticals team have identified evidence of significant cancer mutations.
Drug Response Predicted by Cancer Cell Lines
Large-scale study could increase success rate of developing personalised cancer treatments.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!